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Abstract. This paper considers the task of learning how to make a
prognosis of a patient based on his/her micro-array expression levels.
The method is an application of the aggregation method as recently pro-
posed in the literature on theoretical machine learning, and excels in its
computational convenience and capability to deal with high-dimensional
data. A formal analysis of the method is given, yielding rates of con-
vergence similar to what traditional techniques obtain, while it is shown
to cope well with an exponentially large set of features. Those results
are supported by numerical simulations on a range of publicly available
survival-micro-array datasets. It is empirically found that the proposed
technique combined with a recently proposed preprocessing technique
gives excellent performances.
1. Introduction
Learning how to make a prognosis of a patient is an important ingredient
to the task of building an automatic system for personalised medical treat-
ment. A prognosis here is understood as a useful characterisation of the
(future) time of an event of interest. In cancer research, a typical event is
the relapse of a patient after receiving treatment. The traditional approach
to process observed event times is addressed in the analysis of survival data,
see e.g. [1] for an excellent review of this mature field in statistics. Most of
those techniques are based on parametric or semi-parametric assumptions
on how the data was generated.
Probably the most prevalent technique is Cox’ Proportional Hazard (PH)
approach, where inference is made by maximising a suitable partial like-
lihood function. This approach has proven to be very powerful in many
applications of survival analysis, but it is not clear that the basic assump-
tion underlying this technique holds in the analysis of micro-array datasets.
Specifically, the proportional hazard assumption is hard to verify and might
not even be valid. This in turn jeopardises the interpretation of the re-
sults. This is especially so since the data has typically a high dimensionality
Key words and phrases. Survival analysis, Machine Learning, Micro-array analysis.
2The used software files and datasets are available on http://www.it.uu.se/research/
project/survlab
1
ar
X
iv
:2
00
2.
08
73
1v
1 
 [s
tat
.M
E]
  2
0 F
eb
 20
20
APTER: AGGREGATED PROGNOSIS THROUGH EXPONENTIAL REWEIGHTING2 2
while typically a few (complete) cases are available, incurring problems of
ill-conditioning. Many authors suggested fixes to this problem, see for ex-
amples [2] and references. Some of such work proposed in the early 2000,
was studied numerically and compared in [3]. In applied work, one often
resorts to a proper form of preprocessing in order to use Cox’ PH model,
see e.g. [4].
Since prognosis involves essentially a form of prediction, it is naturally to
phrase this problem in a context of modern machine learning. This insight
allowed a few authors to come up with algorithms which are deviating from
a likelihood-based approach. We mention here [5] and references therein.
This work takes this route even further. It studies the question how can
new insights in machine learning help to build a more powerful algorithm?
As dictated by the application, we are especially interested in dealing with
high-dimensional data. That is, cases where many (O(104)) covariates might
potentially be relevant, while only relatively few cases (O(102)) are available.
Furthermore, we are not so much interested in recovering the mechanisms
underlying the data since that is probably too ambitious a goal. Instead, we
merely aim at making a good prognosis. It is this rationale that makes the
present technique essentially different from likelihood-based, or penalised
likelihood-based approaches as e.g. the PH-L1 [6, 7] or the Danzig Selector
for survival analysis [8], and points us resolutely to methods of machine
learning and empirical risk minimisation.
The contribution of this work is threefold. Firstly, discussion of the ap-
plication of prognosis leads us to formulate a criterion which does not resort
to a standard approach of classification, function approximation or maxi-
mum (partial) likelihood inference. Secondly, we point to the use of ag-
gregation methods in a context of bio-informatics, give a subsequent algo-
rithm (APTER) and derive a competitive performance guarantee. Thirdly,
we present empirical evidence which supports the theoretical insights, and
affirms its use for the analysis of micro-array data for survival analysis.
The experiments can be reproduced using the software made public at
http://www.it.uu.se/research/project/survlab.
1.1. Organization and Notation. This paper is organized as follows. The
next section discusses the setting of survival analyses and the aim of progno-
sis. Section 3 describes and analyses the proposed algorithm. Section 4 gives
empirical results of this algorithms on artificial and micro-array datasets.
Section 4 concludes with a number of open questions.
This paper follows the notational convention to represent deterministic
single quantities as lower-case letters, vectors are denoted in bold-face, and
random quantities are represented as upper-case letters. Expectation with
respect to any random variable in the expression is denoted as E. The
shorthand notation En[·] denotes expectation with respect to all n samples
seen thus far, while En−1[·] denotes expectation with respect to the first
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n − 1 samples. En[·] denotes expectation with respect to the nth sample
only, such that the rules of probability imply that En[·] = En−1En[·].
The data is represented as a set of size n of tuples
(1) {(xi, Yi, δi)}ni=1,
Let 0 < Y1 ≤ Y2 ≤ · · · ≤ Yn be an ordered sequence of observed event
times associated to n subjects. An event can be either a failure with time
Ti, or a (right) censoringtime Ci, expressed as the time elapse from t0. In
this paper we assume that all n subjects share the same time of origin t0.
It will be convenient to assume that each subject has a failure and right
censoring time with values Ti and Ci respectively. Then only the minimum
time can be observed, or Yi = min(Ti, Ci). It will be convenient to define
the past event set P (t) ⊂ {1, . . . , n} at time t. That is, P (t) denotes the set
of all subjects which have experienced an event strictly before time t. Let
for i = 1, . . . , n the indicator δi ∈ {0, 1} denote wether the event (failure)
is directly observed (δi = 1), or if the subject i is censored (δi = 0), or
δi = I(Yi < Ci). Then
(2) P (t) = {i : Yi < t, δi = 1} .
Furthermore, associate to each subject i = 1, . . . , n a covariate xi ∈ Rd of
dimension d. In the present setting, d = O(1000), while n = O(100) at best.
2. Prognosis in Survival Analysis
In this section we formalize the task of learning how to make a prognosis,
based on observed cases. The general task of prognosis in survival analysis
can be phrased as follows:
Definition 1 (Prognosis). Given a subject with covariate x∗ ∈ Rd, what
can we say about the value of its associated T∗?
Motivated by the popular essay by S.J. Gould1, we like to make statements
as ’my covariates indicate that with high probability I will outlive 50% of
the subjects suffering the same disease’, or stated more humanely as ’my
covariates indicate that I belong to the good half of the people having this
disease’. The rationale is that this problem statement appears easier to infer
than estimating the full conditional hazard or conditional survival functions,
while it is more informative than single median survival rates.
Specifically, we look for an expert f : Rd → R which can decide for any
2 different subjects 0 < i, j ≤ n which one of them will fail first. In other
words, we look for an f such that for as many couples (i, j) as possible, one
has
(3) (Ti − Tj) (f(xi)− f(xj)) ≥ 0.
1’The Median Isn’t the Message’ as in http://www.prognosis.org/what_does_it_
mean.php
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Since Tk is not observed in general due to censoring, the following (rescaled)
proxy is used instead
(4)
n∑
i=1
1
|P (Yi)|
∑
j∈P (Yi)
I (f(xi) < f(xj)) ,
where I(z) = 1 if z holds true, and equals zero otherwise. In case |P (Yi)| = 0,
the ith summand in the sum is omitted. This is standard practice in all
subsequent formulae. Note that this quantity is similar to the so called
Concordance Index (Cn) as proposed by Harell [9]. The purpose of this
paper is to propose and analyze an algorithm for finding such f from a large
set {f}, based on observations and under the requirements imposed by the
specific setup.
If given one expert f : Rd → R, its ’loss’ of a prognosis of a subject with
covariate x∗ ∈ Rd and time of event Y∗ would be
(5) `∗(f) =
1
|P (Y∗)|
∑
k∈P (Y∗)
I (f(x∗) ≤ f(xk)) .
That is, `∗(f) is the fraction of samples which experience an event before
the time Y∗ associated to the subject with the covariate x∗, although they
were prognozed with a higher score by expert f . Now we consider having
m experts {fi}mi=1, and we will learn which of them performs best. We
represent this using a vector p ∈ Rm with pi ≥ 0 for all i = 1, . . . ,m, and
with 1Tmp = 1. Then, we will use this weighting of the experts to make an
informed prognosis of the event to occur at T∗, of a subject with covariate
x∗ ∈ Rd. Its associated loss is given as
(6) `∗(p) =
m∑
i=1
pi
 1
|P (T∗)|
∑
k∈P (T∗)
I (fi(x∗) ≤ fi(xk))
 .
This represents basically which expert is assigned most value to for making a
prognosis. For example, in lung-cancer we may expect that an expert based
on smoking behaviour of a patient has a high weight. Note that we include
the ′ =′ case in (6) in order to avoid the trivial cases where f is constant. So,
we have formalised the setting as learning such p in a way that the smallest
possible loss `∗(p) will be (or can be expected to be) made 2.
3. The APTER algorithm
When using a fixed vector pˆ, we are interested in the expected loss of
the rule. The expected loss of the nth sample (xn, Tn) becomes L(pˆ) =
2 Note that different censoring distributions will have a different impact on the of this
simple accuracy measure. However, without too much effort one can compensate for that
as in [10] by a proper weighting scheme. Since this is not essential to the technique per
se, we omit that to the current manuscript.
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En`n(pˆ) =
(7) En
 m∑
i=1
pˆi
1
|P (Tn)|
∑
k∈P (Tn)
I (fi(xn) ≤ fi(xk))
 .
Note that bounds will be given for this quantity which are valid for any xn ∈
Rd which may be provided. In order to device a method which guarantees
properties of this quantity, we use the mirror averaging algorithm as studied
in A. Tsybakov, P. Rigollet, A. Juditsky in [11]. This algorithm is based on
ideas set out in [12]. It is a highly interesting result of those authors that
the resulting estimate has better properties in terms of oracle inequalities
compared to techniques based on sample averages. Presently, such fast
rate is not obtained since the involved loss function is not exponentially
concave as in [11], Definition 4.1. Instead of this property, we resort to use
of Hoeffding’s inequality which gives us a result with rate O(
√
lnm
n ). In
order to give a formal guarantee of the algorithm, the following property is
needed:
Algorithm 1 APTER: Aggregate Prognosis Through Exponential
Reweighting
(0) Let p0i =
1
m for i = 1, . . . ,m, and fix ν > 0.
for all k = 1, . . . , n do
(1) The prognosis associated to the m experts {fi}mi=1 are scored whenever
any new event (censored or not) is recorded for a subject k ∈ {1, . . . , n} at
time Yk as
(8) `k(fi) =
1
|P (Yk)|
∑
l∈P (Yk)
I (fi(xk) ≤ fi(xl))
and the cumulative loss is Lk(fi) =
∑k
s=1 `s(fi).
(2) The vector pk is computed for i = 1, . . . ,m as follows
(9) pki =
exp(−νLk(fi))∑m
j=1 exp(−νLk(fj))
.
end for
(3) Aggregate the hypothesis {pk}k into pˆ as follows:
(10) pˆ =
1
n
n−1∑
k=0
pk.
Definition 2. For any t = 1, . . . , n and i = 1, . . . ,m we have that
(11) En
[
g
(
Ln(fi)
n
)]
= En[g(`t(fi))].
for any regular function g : R→ R.
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This essentially means that we do not expect the loss to be different when
it is measured at different points in time (different subjects).
Theorem 1 (APTER). Given m experts {fi}mi=1, and the loss function `
as defined in eq. (6). Then run the APTER algorithm with ν =
√
2 lnm
n
resulting in pˆ. Then
(12) En−1
[
L(pˆ)− min
i=1,...,m
L(fi)
]
≤
√
2 lnm
n
.
This result is in some way surprising. It says that we can get competitive
performance guarantees without a need for explicitly (numerically) optimiz-
ing the performance over a set of hypothesis. Note that an optimization
formulation lies on the basis of a maximum (partial) likelihood method or
a risk minimization technique as commonly employed in a machine learning
setting. There is an implicit link with optimization and aggregation through
the method of mirror descent, see e.g. [13] and [14]. The lack of an explicit
optimization stage results in the considerable computational speedups. Note
further that the performance guarantee degrades only as
√
log(m) in terms
of the number of experts m.
3.1. Choice of Experts and APTERp. The following experts are used in
the application in micro-array case studies. Here, we use simple univariate
rules. That is, the experts are based on individual features (gene expression
levels) of the dataset. The rationale is that a single gene expression might
well be indicative for the observed behaviours.
Let ei be the ith unit vector, and let ± denote both the positive as well
as the negated version. Then, the experts {fi} are computed as
fi(x) = ±eTi x,
so that m = 2d, and every gene expression level can both be used for over-
expression or under-expression.
In practice however, evidence is found that the following set of experts
result in better performance:
fi(x) = sie
T
i x,
where the sign si ∈ {−1, 1} is given by wether the ith expression has a
concordance index with the observed outcome larger or equal to 0.5, as
estimated on the set used for training. This means that m = d. This
technique is referred to as APTERp. Note that this subtlety needs also
to be addressed in the application of Boosting methods. There, another
popular choice is the use of random trees, see e.g. [15].
3.2. Preprocessing using SIS and ISIS. It is found empirically that
preprocessing using the Iterative Sure Independence Screening ISIS as de-
scribed in [16] improves the numerical results. However, the rational for this
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technique comes from an entirely different angle. That is, it is conceived as
a screening technique for PH-L1-type of algorithms.
The screening rule works as follows. Let m = (m1, ...md)
T ∈ Rd be
defined as
(13) m =
n∑
i=1
Yixi.
For any given γ ∈ (0, 1), define the set Mγ as [16]:
(14) Mγ = {1 ≤ i ≤ d : |mi| is among the first [γn] largest entries of m} .
Here, [γn] denotes the integer part of γn. This set then gives the indices
of the features which are retained in the further analysis. It is referred to
as Sure Independence Screening (SIS) [16]. In the second step, APTER
is applied using only the retained features. Note that in the paper [16],
one suggests instead using a Cox partial Likelihood approach with a SCAD
penalty (for numerical comparison with such scheme, see the next section).
An extension of SIS is Iterative SIS (ISIS), see [16]. The idea is to pick
up important features, missed by SIS. This goes as follows: rather than
having a single preprocessing (SIS) step, the procedure is repeated as follows.
At the end of a SIS-APTER step, a new (semi-) response vector Y ′ can
be computed by application of the found regression coefficients. This new
response variables can then be reused in a SIS step, resulting in fresh [γn]
features. This procedure is repeated until one has enough distinct features.
Since [γn] features are then given as input to the actual training pro-
cedure, we will refer to this value as m in the experiments, making this
connection between screening and training more explicit.
4. Empirical Results
This section present empirical results supporting the claim of efficiency.
First, we describe the setup of the experiments.
4.1. Setup. The following measure of quality (the Concordance index or
Cn or C-index, see e.g [17]) of a prognostic index scored by the function
f : Rd → R is used. Let again the data be denoted as {(xi, Yi, δi)}ni=1, where
xi are the covariates, Yi contains the survival- or censoring time, and δi is
the censoring indicator as before. Consider any f : Rd → R, then Cn is
defined as
(15) Cn(f) =
∑
i:δi=1
∑
Yj>Yi
I(f(xi) < f(xj))
|ε| .
Here |ε| denotes the number of the pairs which have Yi < Yj when Yi is not
censored. The indicator function I(pi) = 1 if pi holds, and equals 0 otherwise.
That is, if Cn(f) = 1, one has that f scores a higher prognostic index to the
subject with will experience the event later (’good’). A Cn(f) = 0.5 says
that the prognostic index given by f is arbitrary with respect to event times
(’bad’). Observe that this measure is not quite the same as `n(f) or Ln(f)
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as were used in the design of the APTER algorithm. Note that this function
goes along the lines of the Area under the ROC curve or the Mann-Whitney
statistic, adapted to handling censored data.
The data is assigned randomly to training data of size nt = b2n/3c and
test data of size n − nt. The training data is used to follow the training
procedures, resulting in fˆ . The test data is used to compute the performance
expressed as Cn(fˆ). The results are randomised 50 times (i.e. a random
assignments to training and test set), and we report the median value as well
as ± the variance. The parameter ν > 0 is tuned in the experiments using
cross-validation on the dataset which is used for training. It was found that
proper tuning of this parameter is crucial for achieving good performance.
The following ten algorithms are run on each of these datasets:
(a) APTER: The approach as given in Alg. 1 where experts {fi, f ′i} are
taken as fi(x) = e
T
i x and f
′
i(x) = −eTi x. In this way we can incor-
porate positive effects due to over-expression and under-expression
of a gene. This means that m = 2d.
(b) APTERp: The approach as given in 1 where experts {fi} are given
as fi(x) = sie
T
i x where the sign si ∈ {−1, 1} is given by the Cn
of the ith expression with the observed effect, estimated on the set
used for training. This means that m = d.
(c) MINLIPp: The approach based on ERM and si as discussed in [18].
(d) MODEL2: Another approach based on ERM as discussed in [18].
(g) PLS: An approach based on preprocessing the data using PLS and
application of Cox regression, as described in [3].
(f) PH-L1: An approach based on a L1 penalized version of Cox regres-
sion, as described in [6].
(g) PH-L2: An approach based on a L2 penalized version of Cox regres-
sion, as described in [19].
(h) ISIS-APTERp: An approach which uses ISIS as preprocessing, and
applies APTERp on the resulting features [16].
(i) ISIS-SCAD: An approach which uses ISIS as preprocessing, and ap-
plies SCAD on the resulting features [16].
(j) Rankboost: An approach based on boosting the c-index [20].
Those algorithms are applied to an artificial dataset (as described below)
as well as on a host of real-world datasets (as can be found on the website).
Those datasets are publicly available, and all experiments can be reproduced
using the code available at 3.
4.2. Artificial Data. The technique is tested on artificial data which was
generated as follows. A disjunct training set and test set, both of size 100
’patients’ was generated. For each ’patient’, d features are sampled randomly
from a standard distribution, so that xi ∈ Rd.
3The software is available at http://www.it.uu.se/research/project/survlab
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We say that we have only k informative features when an event occurs at
time Ti computed for i = 1, . . . , n as
(16) Ti =
− logZi
10 exp
(∑k
j=1 xi,j
) ,
where Zi is a random value generated from a uniform distribution on the
unit interval ]0, 1[, and xi,j is the jth covariate for the ith patient. The right-
censoring time is randomly generated from the exponential distribution with
rate 0.1. After application of the censoring rule, we arrive at the survival
time Yi.
In a first experiment, d is fixed as 100, but only the first k ≤ d features
have an effect on the outcome (’informative’). Figure (1.a) shows the evo-
lution of the performance (Cn(fˆ)) for increasing values of k. In a second
experiment we fix k = 10, and record the performance for increasing values
of d, investigating the effect of a growing number of ambient dimension on
the performance of APTER. Results are displayed in Figure (1.b).
Thirdly, we investigate how well the numerical results align with the result
of Theorem 1. We take results of APTER using univariate experts, so that
m = 2d. The ”c-index error” (Cerr) is given for different values of d and n.
Cerr is computed as the difference between the Cn obtained by APTER -
denoted as fˆ - and the Cn of the single ”best” expert fj(xi) = xi,j :
(17) Cerr = max
j
Cn(fj)− Cn
(
fˆ
)
.
This formula is similar to equation (12). The numerical performances are
displayed in Figure (1.c). This figure indicates that Cerr increases loga-
rithmically in d, and in terms of 1√
n
. This supports the result of Theorem
1.
4.3. Real Datasets. In order to benchmark APTER and its variations
against state-of-the-art approaches, we run the algorithms on a wide range
of large-dimensional real datasets. The dataset are collected in a context
of bioinformatics, and a full description of this data can be found on the
website. The experiments are divided into three categories:
(i) The algorithms are run on seven micro-array datasets, in order to asses
performance on typical sizes for those datasets. Here we see that there is
no clear overall winner amongst the algorithms, but the proposed algorithm
(ISIS-APTERp) does do repeatedly very well, and performs best on most
datasets. Results are given in Table (1).
(ii) In order to see wether the positive performance is not due to irreg-
ularities of the data, we consider the following null experiment. Consider
the AML dataset, but lets shuffle the observed phenotypes (the observed Y )
between different subjects. So any relation between the expression level and
the random phenotype must be due to plain chance (by construction). We
see in Figure (2,a) that indeed the distribution of the methods based on this
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Figure 1. Comparison of the numerical results obtained
on the artificial data sets (a) when keeping d = 100 fixed,
and (b) when keeping k = 10 fixed. (c) The evolution of
the ’C-index error’ Cerr obtained by APTERp for different
values of (n,m).
shuffled data nears a neutral Cn on the test set of 0.50. This means that the
10% improvement as found in the real experiment (see table) is substantial
with respect to the randomizations, and are not due to chance alone.
(iii) The results of the algorithm is compared on the micro-array dataset
as reported in [21], and analysed further in [22]. Here we found that the
obtained performance is significantly larger than what was reported earlier,
while we do not have to resort to the clustering preprocessing as advocated
in [21, 22]. This data has a very high dimensionality (d = 44.928) and has
only a few cases (n = 191). Results are given in Table (2) and the box plots
of the performances due to the 50 randomisations, are given in Figure (2.b).
Finally, we discuss the application of the method on the same high-
dimensional (d = 44.928) dataset as before, but we study the impact of
the parameter m given to ISIS, which returns in turn the data to be pro-
cessed by APTERp. The performances for different values of m are given in
Fig. (3.a). The best performance is achieved for m = 800, which is the value
which was used in the earlier experiment reported in Fig. (2.b). Here we
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Figure 2. (a) Performances of APTER and APTERp on
the AML dataset when the reposes are randomly shuffled.
(b) Boxplots of the numerical results obtained on the FL
dataset. Results are expressed in terms of the Cn(f) on a
test set, where f is trained and tuned on a disjunct training
set. The boxplots are obtained using 50 randomizations of
the split training-testset.
compare only to a few other approaches, namely the PH-L1, MINLIPp and
MODEL2 approach which make all use of an explicit optimisation scheme.
Panel (3.b) reports the time needed to perform training/ tuning and ran-
domisation corresponding to a fixed value of m. Panel (3.c) reports the size
of the memory used up for the same procedure. Here it is clearly seen that
APTERp results in surprisingly good performance, given that it uses up less
computations and memory. It is even so that the optimisation-based tech-
niques cannot finish for large m in reasonable time or without problems of
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the memory management, despite the fact that a very efficient optimisation
solver (Yalmip) was used to implement those.
4.4. Discussion of the Results. These results uncover some interest-
ing properties of the application of the proposed algorithms in this bio-
informatics setting.
First of all, the APTER and APTERp methods are orders of magni-
tudes faster (computationally) compared to the bulk of methods based on
optimization formulations (either using Maximum (penalized) Partial Like-
lihood, Empirical Risk Minimization or multivariate preprocessing tech-
niques). This does not affect the performance in any way, contrary to what
intuition would suggest. In fact, the performance on typical micro-array
data of the vanilla APTER or APTERp (without ISIS) is often amongst the
better.
Secondly, inclusion of preprocessing with ISIS - also very attractive from
a computational perspective - is boosting up significantly the performance of
APTER. We have no theoretical explanation for this, since ISIS was designed
to complement L1 or Danzig-selector approaches. While the authors of ISIS
advocate the used of a SCAD-based approach based on empirical evidence,
we find that APTERp is overall a better choice for the mentioned datasets.
It becomes clear by looking for example to the results on the FL dataset,
that ISIS per se is not causing the boost in performance. However, the
combination of ISIS and APTERp seems to perform surprisingly well.
Furthermore, the empirical results indicate that the statistical perfor-
mance is preserved by using APTERp combined with ISIS, and may even
improve over performances obtained using existing approaches. This is re-
markable since the computational power is orders of magnitude smaller than
most existing approaches based on (penalised) PL of ERM. We find also that
empirical results align quite closely the theoretical findings as illustrated
with an experiment on artificial data. 4
5. Conclusions
This paper presents statistically and computationally compelling argu-
ments for a method based on aggregation can be used for analysis of survival
data in high dimensions. Theoretical findings are complemented with em-
pirical results on micro-array datasets. We feel that this result is surprising
not only in that it outperforms methods in ERM or (penalised) PL, but pro-
vides as well a tool with much lower computational complexity as the former
ones since no direct optimization is involved. We present empirical, repro-
ducible results which support this claim of efficiency. This analysis presents
4As is common for such case-studies, there is considerable uncertainty (variability) of
the results (see e.g. the box plots in Fig. (2)). However, since results are calculated on
independent test-sets, this does not indicate overfitting. Note that this is supported by
the theory indicating that the technique can deal with large sets of covariates without
overfitting on the data.
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Figure 3. results of the choice of m in ISIS, based on the
Follicular Lymphoma dataset[21, 22]. (a) Performance ex-
pressed as Cn(fˆ) on the test sets (medium (±) of 50 random-
izations). (b) Computation time for running tuning, training
and randomisation for a fixed value of m. (c) Usage of mem-
ory of the same procedure.
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many new opportunities, both applied (towards Genome Wide Analysis, or
GWAs) as well as theoretical (can we improve the rates of convergence by
choosing other loss functions?).
Appendix A. Proof of Theorem 1
The following results will be used.
Lemma 1 (Hoeffding). Let λ ∈ R, and let X be a random variable taking
values in [a, b] ⊂ R, then
(18) lnE [exp(λX)] ≤ λE[X] + λ
2(b− a)2
8
.
With assumption of eq. (11) in hand, the following result holds:
Lemma 2. Given m experts {fi : Rd → R}mi=1, a loss function ` : R → R
satisfying eq. (11), and let {(xk, Yk, δk)}nk=1 take values in Rd×R+×{0, 1}.
Let the APTER algorithm (1) be run with a fixed ν > 0, then
(19) En−1
[
L(pˆ)− min
i=1,...,m
L(fi)
]
≤ lnm
νn
+
1
ν
En[Rn],
with
(20) Rn =
1
ν
n∑
t=1
ln Eˆ exp−ν
(
`n(f)− Eˆ`n(f)
)
.
and Eˆg(f) =
∑m
i=1 pˆig(fi) for any g.
Proof. Consider the evolution of the normalization terms Wt where
(21) Wt =
m∑
i=1
exp−νLt(fi),
is characterized. Specifically, we see that
(22) ln
Wn
W0
= ln
m∑
i=1
exp(−νLn(fi))− lnm ≥ −ν min
i=1,...,m
Ln(fi)− lnm,
as before. Hence
(23)
1
nν
En
[
ln
Wn
W0
]
≥ − min
i=1,...,m
En
[
1
n
Ln(fi)
]
− lnm
nν
≥ − min
i=1,...,m
En [`n(fi)]− lnm
nν
≥ − min
i=1,...,m
En−1L(fi)− lnm
nν
.
On the other hand we have that
(24) ln
Wt
Wt−1
= ln
∑m
i=1 exp(−νLt(fi))∑m
j=1 exp(−νLt−1(fj))
= ln
m∑
i=1
pt−1i (exp−ν`t(fi)) .
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Taking expectation over the n samples (denoted as En[·]) seen thus far, and
summarizing over t = 1, . . . , n gives
(25)
1
nν
n∑
t=1
En [lnWt − lnWt−1]
=
1
nν
n∑
t=1
En
[
ln
m∑
i=1
pt−1i exp−ν`t(fi)
]
=
1
nν
n∑
t=1
En
[
ln
m∑
i=1
pt−1i exp−ν
Ln(fi)
n
]
=
1
nν
n∑
t=1
En
[
ln
m∑
i=1
pt−1i exp−ν`n(fi)
]
≤ 1
ν
En
[
ln
m∑
i=1
pˆi exp−ν`n(fi)
]
,
where the last inequality follows from Jenssen’s inequality, and from the
formula of aggregation as in eq. (10). Now, this gives
(26)
1
ν
En
[
ln Eˆ exp−ν`n(f)
]
=
1
ν
En
[
ln Eˆ exp−νEˆ`n(f)
]
+
1
ν
En
[
ln Eˆ exp−ν
(
`n(f)− Eˆ`n(f)
)]
= −En−1En[Eˆ`n(f)]
+
1
ν
En
[
ln Eˆ exp−ν
(
`n(f)− Eˆ`n(f)
)]
,
where we defined for notational convenience Eˆx =
∑m
i=1 pˆixi for all x ∈ Rm,
and Eˆ`n(f) =
∑m
i=1 pˆi`n(fi). Combining inequalities (23) and (26) gives
(27) En−1
[
L(pˆ)− min
i=1,...,m
L(fi)
]
≤ lnm
νn
+
1
ν
En[Rn],
as desired.  
So we are left to proof that the term En[Rn] is bounded in our case. The
proof of Theorem 1 is then given as follows.
Proof. This follows by application of Hoeffding’s inequality as in eq. (18)
since
(28) Rn = ln Eˆ exp−ν
(
`n(f)− Eˆ`n(f)
)
≤ ν
2
2
,
where we use that 0 ≤ `n ≤ 1. Then combining with eq. (19) gives the
result.  
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Appendix B. Benchmark datasets
This appendix describes the real-world datasets. The datasets range from
large-dimensional (d = O(100)) to huge-dimensional (d = O(10, 000)), and
record n = O(100) subjects. We report the performance of different methods
on:
• 7 publicly available datasets containing micro-array expression levels
and events (occurrence of disease) of the associated subjects as used
in [3].
• The micro-array survival dataset as presented in [21] and analysed
in the report [22].
Details are given below. The 7 publicly available micro-array datasets as
used for benchmarking in [3], have the following properties.
(NSBCD): The Norway/Stanford Breast Cancer Data set is given in [23]. In
this database there are survival data of n = 115 women who have
breast cancer, and d = 549 intrinsic genes introduced in [23] were
measured. In the 115 patients, 33% (38) have experienced an event
during the study. Missing values were imputed by the 10-nearest
neighbour method.
(Veer): The survival data of sporadic lymph-node-negative patients with
their gene expression profiles is given in [4]. It has n = 78 pa-
tients with d = 4751 gene expressions selected from the 25,000 genes
recorded with the micro-array. 44 patients remained free of disease
after their diagnosis for an interval of at least 5 years. The aver-
age follow-up time for these patients was 8.7 years. 34 patients had
developed distant metastases within 5 years, and the mean time to
metastases was 2.5 years.
(Vijver): The data set of n = 295 consecutive patients with primary breast
carcinomas is from [4] All patients had stage I or II breast cancer
and were younger than 53 years old. They gave the previously de-
termined d = 70 marker genes that are associated with the risk of
early distant metastases in young patients with lymph-node-negative
breast cancer. The median follow-up among all 295 patients was 6.7
years (range, 0.05 to 18.3). There were no missing data. 88 patients
have experienced an event during the study.
(DBCD): The Dutch Breast Cancer Data set is described in [24], and is a sub-
set of the data from [4]. There are survival data of n = 295 women
who have breast cancer. The measures of d = 4919 gene expres-
sion were taken from the fresh-frozen-tissue bank of the Netherlands
Cancer Institute. All the ages of the patients are smaller than or
equal to 52 years. The diagnosis was made between 1984 and 1995
without previous history of cancer. The median of follow-up time
was 6.7 years (range 0.05-18.3). In the 295 patients, 26.78% (79)
have experienced an event during the study.
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(DLBCL): The diffuse large-B-cell lymphoma data set is described in [25]. This
contains survival data of n = 240 patients who have diffuse large-
B-cell lymphoma. d = 7399 different gene expression measurements
are given. The median of follow-up time was 2.8 years. From the
240 patients, 58% have experienced an event during the study.
(Beer): The survival data of n = 86 patients with primary lung adenocar-
cinomas is from [26] There are d = 7129 expressed genes selected
from Affymetrix hu6800 micro-arrays. 76 patients have experienced
an event during the study.
(AML): The survival data of acute myeloid leukemia patients is described in
[27]. It contains n = 116 patients with acute myeloid leukemia and
the expression levels of d = 6283 genes. 71 patients have experienced
an event during the study.
The same datasets were used in [3] and [5] to benchmark state-of-art meth-
ods, results that are reproduced here as well.
(FL): Additionally, we use the micro-array dataset which was used in [21],
and analysed in [22]. This dataset included the survival data of
n = 191 patients with follicular lymphomas, where t0 equals the
respective time of diagnosis. The median age at diagnosis was 51
years (range, 23 to 81), and the median follow-up time was 6.6 years
(range, less than 1.0 to 28.2). The median followup time among
the patients alive at the final follow-up was 8.1 years. It contains
d = 44928 gene expression levels selected from Affymetrix U133A
and U133B micro-arrays.
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NSBCD DBCD DLBCD Veer Vijver Beer AML
(115× 549) (295× 4919) (240× 7399) (78× 4751) (295× 70) (86× 7129) (116× 6283)
APTER 0.73±0.10 0.69±0.06 0.58±0.04 0.65±0.10 0.44±0.06 0.60±0.13 0.58±0.05
APTERp 0.77±0.05 0.74±0.04 0.59±0.03 0.68±0.08 0.62±0.04 0.73±0.08 0.60±0.05
MINLIPp 0.74±0.05 0.71±0.04 0.59±0.04 0.65±0.10 0.61±0.06 0.69±0.09 0.55±0.07
MODEL2 0.75±0.04 0.74±0.04 0.62±0.03 0.67±0.09 0.61±0.06 0.74±0.08 0.56±0.06
PLS 0.78±0.05 0.74±0.03 0.53±0.05 0.58±0.10 0.62±0.07 0.66±0.12 0.57±0.06
PH-L2 0.69±0.07 0.73±0.04 0.65±0.04 0.64±0.08 0.61±0.08 0.73±0.08 0.54±0.06
PH-L1 0.69±0.06 0.74±0.04 0.60±0.04 0.60±0.06 0.65±0.06 0.69±0.02 0.61±0.06
Rankboost 0.75±0.04 0.72±0.03 0.62±0.02 0.62±0.02 0.65±0.02 0.71±0.02 0.53±0.01
ISIS-SCAD 0.69±0.04 0.72±0.04 0.65±0.07 0.68±0.04 0.62±0.02 0.72±0.04 0.63±0.02
ISIS-APTERp 0.78±0.06 0.76±0.08 0.62±0.07 0.66±0.05 0.62±0.06 0.75±0.09 0.59±0.05
Table 1. This table reports the Cn(fˆ) as computed on an in-
dependent test set (median ± variance on 50 randomisations)
of the experiments of 10 different methods on 7 micro-array
datasets.
Dataset Method Cn(fˆ)
FL APTER 0.70±0.05
(191× 44928) APTERp 0.73±0.04
MINLIPp 0.70±0.03
MODEL2 0.72±0.04
PLS 0.66±0.03
PH-L2 0.69±0.07
PH-L1 0.67±0.05
RankBoost 0.67±0.03
ISIS-SCAD 0.71±0.03
ISIS-APTERp 0.74±0.05
Dave’s Method (see [22]) 0.71±0.02
Table 2. Numerical results of the experiments of 10 differ-
ent methods on the Follicular Lymphoma dataset.
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